Blood NAD Levels May Offer Clues to Cardiovascular Health

By LabMedica International staff writers
Posted on 18 Nov 2026

Nicotinamide adenine dinucleotide (NAD) is an essential molecule involved in cellular metabolism and energy production. Blood NAD has attracted attention because NAD-boosting supplements are promoted for healthy aging, yet human blood findings have been inconsistent. The key diagnostic question is whether whole-blood NAD reflects normal aging or disease-related biology. New findings demonstrate that whole-blood NAD levels are linked to cardiovascular disease rather than declining universally with age.

Vilnius University researchers evaluated whole-blood NAD measurement in 1,068 adults, including healthy individuals and people with chronic diseases. The study included 1,340 NAD measurements obtained from dried blood spot samples collected under standardized conditions. The analysis examined whether NAD levels change with chronological age and whether chronic disease status is associated with differences in measured levels.


Image: Top (green): in healthy adults, whole-blood NAD does not decline with age (stable in men and rises in women). Bottom (red): in people with chronic disease, NAD is lower (it declines with age in men, and the increase seen in healthy women disappears). Lower NAD is most clearly associated with cardiovascular disease, particularly hypertension. (Image Credit: Vilnius University, Dalius Ratautas)

Among healthy adults, whole-blood NAD did not decline with age. Levels remained stable in men and increased modestly but significantly in women. In contrast, NAD levels were lower in people with cardiovascular disease, with the clearest differences observed among participants with hypertension.

The findings were published in Nature Metabolism and challenge the assumption that declining blood NAD is a universal feature of human aging. The researchers emphasized that the study does not establish whether lower NAD contributes to cardiovascular disease, results from the disease, or reflects other underlying factors. They also stated that the study does not show that increasing NAD through supplementation can prevent or treat cardiovascular disease or hypertension.

The work also addressed whether blood NAD can reflect NAD levels in tissues such as muscle or the brain. A commentary published alongside the study highlighted limitations of using blood NAD as a proxy for tissue NAD because red blood cells account for most whole-blood NAD and have different metabolic characteristics from other cell types. The researchers noted that blood biomarkers can still provide clinically useful information, and identified future work on cardiovascular risk prediction and mechanisms linking NAD levels with cardiovascular disease as the next step.

“For years, the prevailing narrative has been that NAD declines as we age and therefore needs to be restored. Our findings suggest that this is not what happens in the blood of healthy adults,” said Dr. Dalius Ratautas, who led the research at Vilnius University. 

“Instead, we found a clear association between lower NAD levels and cardiovascular disease. This raises a different and potentially important question: could NAD levels tell us something about cardiovascular health?” added Dr. Ratautas.

Related Links
Vilnius University


Latest BioResearch News